The efficacy of octreotide LAR as firstline therapy for patients with newly diagnosed acromegaly is independent of tumor extension: predictive factors of tumor and biochemical response.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples